Advanced BioHealing to be Acquired by Shire for $750 Million
Earlier this afternoon, life sciences partner company Advanced BioHealing (ABH) announced it had signed a definitive agreement to be acquired by Shire plc (LSE: SHP,…
Posted by
Safeguard Insights
Safeguard Scientifics Honored with Investment Deal of the Year at PACT Enterprise Awards
Last night, I had the pleasure of attending the Greater Philadelphia Alliance for Capital and Technologies (PACT) 18th Annual Enterprise Awards. For nearly 60 years,…
Posted by
Safeguard Scientifics to Announce First Quarter 2011 Financial Results on April 27
Safeguard Scientifics will release its financial results for the first quarter ended March 31, 2011 prior to market open on Wednesday, April 27. At 9 a.m.…
Posted by
Safeguard Scientifics Fourth Quarter and Year-End Financial Results Recap, Highlighting Aggregate Partner Company Revenue Growth, Acquisitions and IPOs
This morning, we announced our fourth quarter and year-end 2010 financial results. In 2010, our aggregate partner company revenue was $403 million, up 54 percent…
Posted by
Safeguard Scientifics Aggregate Partner Company Revenue Exceeds $400 Million in 2010
Safeguard Scientifics’ value creation strategy is to deploy capital and build value in our partner companies. One of the best ways to evaluate our progress is…
Posted by
Communicating Value and Increasing Transparency
Cash on our balance sheet may be growing with every well-timed exit transaction and positive momentum is driving Safeguard’s stock price upward; however, our IR…
Posted by
Partner Company Clarient (Nasdaq: CLRT) to be Acquired by GE Healthcare for $587 Million
At Safeguard Scientifics, our strategy is to provide growth capital for entrepreneurial and innovative life sciences and technology companies, build value in those companies and…
Posted by
Safeguard Scientifics Relaunches Website, Blog
Welcome to the newly redesigned Safeguard Scientifics blog! And if you haven’t been over to our website yet, check it out — we’ve transformed that…
Posted by
Strong Diversification Strategy Can Thwart Grim VC Numbers
The data from Thomson Reuters/NVCA on venture capital investing over the past 10 years has sparked an onslaught of debate and media coverage highlighting the…
Posted by
